Parent-Only Financial Statements (Tables) - Parent [Member]
|
12 Months Ended |
Dec. 31, 2025 |
|---|
| Parent-Only Financial Statements (Tables) [Line Items] |
|
| Schedule of Condensed Balance Sheets |
The following represents condensed financial information
of the parent company:
| | |
As of December 31, | |
| | |
2024 | | |
2025 | |
| | |
RMB | | |
RMB | | |
US$ | |
| ASSETS/(LIABILITIES) | |
| | |
| | |
| |
| Cash and cash equivalents | |
| 2,227,649 | | |
| 42,095 | | |
| 5,989 | |
| Short-term investments | |
| — | | |
| 26,214,992 | | |
| 3,729,654 | |
| Prepayments | |
| 891 | | |
| — | | |
| — | |
| Due from intercompany | |
| 814,547,651 | | |
| 1,160,984,732 | | |
| 165,175,383 | |
| Investment in subsidiaries | |
| (585,987,070 | ) | |
| (438,947,877 | ) | |
| (62,449,903 | ) |
| TOTAL ASSETS | |
| 230,789,121 | | |
| 748,293,942 | | |
| 106,461,123 | |
| SHAREHOLDERS’ EQUITY | |
| | | |
| | | |
| | |
| Shareholders’ equity (deficit): | |
| | | |
| | | |
| | |
| Class A ordinary shares (US$0.002 par value; 14,141,093 and 1,097,141,091 shares authorized as of December 31, 2024 and 2025, respectively; 13,273,596 and 20,712,924 shares issued as of December 31, 2024 and 2025, respectively; 12,815,143 and 20,185,908 shares outstanding as of December 31, 2024 and 2025, respectively) | |
| 176,842 | | |
| 283,565 | | |
| 40,343 | |
| Class B ordinary shares ($0.002 par value; 2,858,909 shares authorized; 2,858,909 shares issued and outstanding as of December 31, 2024 and 2025) | |
| 36,894 | | |
| 36,894 | | |
| 5,249 | |
| Treasury shares | |
| — | | |
| (1,666,859 | ) | |
| (237,147 | ) |
| Additional paid-in capital | |
| 780,499,664 | | |
| 1,180,196,429 | | |
| 167,908,666 | |
| Accumulated deficit | |
| (565,218,741 | ) | |
| (429,752,701 | ) | |
| (61,141,689 | ) |
| Statutory reserves | |
| 6,647,109 | | |
| 6,647,109 | | |
| 945,696 | |
| Accumulated
other comprehensive income (loss) | |
| 8,647,353 | | |
| (7,450,495 | ) | |
| (1,059,995 | ) |
| TOTAL NANO LABS LTD SHAREHOLDERS’ EQUITY | |
| 230,789,121 | | |
| 748,293,942 | | |
| 106,461,123 | |
|
| Schedule of Condensed Statements of Operations and Comprehensive Income (Loss) |
| |
|
For the years ended December 31, |
|
| |
|
2023 |
|
|
2024 |
|
|
2025 |
|
| |
|
RMB |
|
|
RMB |
|
|
RMB |
|
|
US$ |
|
| Net revenues |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
| Operating expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Selling and marketing expenses |
|
|
— |
|
|
|
— |
|
|
|
(607,147 |
) |
|
|
(86,379 |
) |
| General and administrative expenses |
|
|
(471,664 |
) |
|
|
(683,178 |
) |
|
|
(1,016,420 |
) |
|
|
(144,607 |
) |
| Change in fair value of cryptocurrencies |
|
|
— |
|
|
|
— |
|
|
|
3,383,727 |
|
|
|
481,409 |
|
| Total operating income (expenses) |
|
|
(471,664 |
) |
|
|
(683,178 |
) |
|
|
1,760,160 |
|
|
|
250,423 |
|
| Income (loss) from operations |
|
|
(471,664 |
) |
|
|
(683,178 |
) |
|
|
1,760,160 |
|
|
|
250,423 |
|
| Finance income (expense) |
|
|
110,971 |
|
|
|
(13,140 |
) |
|
|
— |
|
|
|
— |
|
| Interest expense |
|
|
— |
|
|
|
— |
|
|
|
(5,952,207 |
) |
|
|
(846,832 |
) |
| Other expenses |
|
|
— |
|
|
|
— |
|
|
|
(9,073,955 |
) |
|
|
(1,290,968 |
) |
| Income (loss) from investment in subsidiaries |
|
|
(252,463,079 |
) |
|
|
(112,490,730 |
) |
|
|
148,732,042 |
|
|
|
21,160,375 |
|
| Net income (loss) attributable to Nano Labs Ltd |
|
|
(252,823,772 |
) |
|
|
(113,187,048 |
) |
|
|
135,466,040 |
|
|
|
19,272,998 |
|
| Comprehensive income (loss): |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Net income (loss) |
|
|
(252,823,772 |
) |
|
|
(113,187,048 |
) |
|
|
135,466,040 |
|
|
|
19,272,998 |
|
| Other comprehensive income (loss) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Foreign currency translation adjustment |
|
|
155,229 |
|
|
|
6,392,795 |
|
|
|
(16,097,848 |
) |
|
|
(2,290,270 |
) |
| Total comprehensive income (loss) attributable to Nano Labs Ltd |
|
|
(252,668,543 |
) |
|
|
(106,794,253 |
) |
|
|
119,368,192 |
|
|
|
16,982,728 |
|
|
| Schedule of Condensed Statements of Cash Flows |
| | |
For the years ended December 31, | |
| | |
2023 | | |
2024 | | |
2025 | |
| | |
RMB | | |
RMB | | |
RMB | | |
US$ | |
| Net cash provided by (used in) operating activities | |
| 344,012 | | |
| (281,829 | ) | |
| (4,118,150 | ) | |
| (585,897 | ) |
| Net cash used in investing activities | |
| (68,918,960 | ) | |
| (312,142,434 | ) | |
| (363,723,160 | ) | |
| (51,747,547 | ) |
| Net cash provided by financing activities | |
| 72,802,734 | | |
| 315,620,394 | | |
| 355,632,852 | | |
| 50,596,525 | |
| Effect of exchange rate changes on cash and cash equivalents | |
| (3,047,562 | ) | |
| (2,174,475 | ) | |
| 10,022,904 | | |
| 1,425,976 | |
| Net increase (decrease) in cash and cash equivalents | |
| 1,180,224 | | |
| 1,021,656 | | |
| (2,185,554 | ) | |
| (310,943 | ) |
| Cash and cash equivalents at beginning of the year | |
| 25,769 | | |
| 1,205,993 | | |
| 2,227,649 | | |
| 316,932 | |
| Cash and cash equivalents at end of the year | |
| 1,205,993 | | |
| 2,227,649 | | |
| 42,095 | | |
| 5,989 | |
|